OptiBiotix Health Plc. is a life sciences company operating in one of the most progressive areas of biotechnological research.

Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits.

With an established pipeline of microbiome modulators, the OptiBiotix team works today in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles, and diabetes.

The OptiBiotix Difference: Better Science, Better Health

Everything we do is underpinned by strong science, backed by human studies, and supported by key opinion leaders, allowing us to deliver quality ingredients and superior white label food and supplement solutions.


OptiBiotix Health is developing a range of technologies, which modulate the human microbiome to prevent and manage human disease. A global market of strategic interest to pharmaceutical, food, health and wellbeing companies, the human microbiome is forecast to become one of the world’s fastest growth areas. Find Out More